StockData

KORU Medical Systems vs Sonoma Pharmaceuticals

KRMD and SNOA side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How KRMD and SNOA compare

KORU Medical Systems is the larger company, worth 33 times as much as Sonoma Pharmaceuticals ($171M against $5.2M).

Sonoma Pharmaceuticals grew revenue faster over the last twelve months (38.7% versus 18.4% for KORU Medical Systems).

KORU Medical Systems keeps more of each dollar of sales as profit, with a net margin of −1.8% compared with −7.6% at Sonoma Pharmaceuticals.

KORU Medical Systems scores higher on the StockData Score (13 against 11 for Sonoma Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricKRMDSNOA
Size and price
Market cap$171M$5.2M
Share price$3.70$1.09
Change, 1 year−2.1%−70.4%
Change, 5 years8.8%−99.0%
Beta (5Y)1.001.93
Employees73250
StockData Score
Total score13 (better)11
Valuation score03 (better)
Growth score4 (better)3
Performance score3 (better)2
Health score6 (better)3
Dividend score00
Valuation
P/S3.7×0.2× (better)
P/B8.8×0.8× (better)
EV/EBITDA822×–
FCF yield−0.23% (better)−53.4%
Fair value–$4.95
Margin of safety–78.0%
Growth
Revenue growth (TTM)18.4%38.7% (better)
Revenue growth, 5Y average11.2% (better)0.95%
Profitability
Gross margin63.6% (better)39.2%
Operating margin−1.3% (better)−3.3%
Net margin−1.8% (better)−7.6%
FCF margin−0.84% (better)−11.9%
Return on equity−4.6% (better)−34.5%
Return on invested capital−4.7% (better)−42.9%
Financial health
Debt / equity0.000.01 (better)
Current ratio2.973.48 (better)
Altman Z-score11.44 (better)−14.20
Piotroski F-score5 (better)3
Dividends and buybacks
Buyback yield–−81.9%
Shareholder yield0.00% (better)−81.9%
Ownership
Held by institutions44.5%2.3%
Held by insiders17.6%11.1%
Insider net buying, 12 months$1.6M–
Short interest, % of float2.3%1.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.